As a variety cannabis products are introduced into the medical field, both industry and institutions are facing the challenges of a new, rapidly-evolving policy environment being built on the backbone of an old and strained system of medical regulations.

Hanway Associates is proud to announce that we have become the first European member of the Global Cannabis Partnership (GCP).

The past six months have seen an unprecedented rate of change for both the global and European cannabis industry. Today, for the first time, patients across the United Kingdom will be able to be prescribed a range of cannabis-based medicinal products.

Cannabis Europa Paris will take place on 8 February 2019, and Cannabis Europa London will take place on the 24-25 June 2019.